Heinrich Iber

700 total citations
14 papers, 564 citations indexed

About

Heinrich Iber is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Heinrich Iber has authored 14 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Organic Chemistry. Recurrent topics in Heinrich Iber's work include Glycosylation and Glycoproteins Research (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Heinrich Iber is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Heinrich Iber collaborates with scholars based in Germany and United States. Heinrich Iber's co-authors include Konrad Sandhoff, Edward T. Morgan, G. van Echten, Qi Chen, Marion B. Sewer, Akira Takatsuki, Henrik U. Stotz, Po‐Yung Cheng, Tong Li and Yu Sheng and has published in prestigious journals such as FEBS Letters, Journal of Neurochemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Heinrich Iber

14 papers receiving 557 citations

Peers

Heinrich Iber
Michael J. Ernest United States
A Radomińska-Pyrek United States
R L Veech United States
H. P. Morris United States
Monica Einstein United States
Michael J. Ernest United States
Heinrich Iber
Citations per year, relative to Heinrich Iber Heinrich Iber (= 1×) peers Michael J. Ernest

Countries citing papers authored by Heinrich Iber

Since Specialization
Citations

This map shows the geographic impact of Heinrich Iber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinrich Iber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinrich Iber more than expected).

Fields of papers citing papers by Heinrich Iber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinrich Iber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinrich Iber. The network helps show where Heinrich Iber may publish in the future.

Co-authorship network of co-authors of Heinrich Iber

This figure shows the co-authorship network connecting the top 25 collaborators of Heinrich Iber. A scholar is included among the top collaborators of Heinrich Iber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinrich Iber. Heinrich Iber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Iber, Heinrich, et al.. (2001). Regulation of Hepatic Cytochrome P450 2C11 via cAMP: Implications for Down-Regulation in Diabetes, Fasting, and Inflammation. Journal of Pharmacology and Experimental Therapeutics. 297(1). 174–180. 38 indexed citations
2.
Iber, Heinrich, Qi Chen, Po‐Yung Cheng, & Edward T. Morgan. (2000). Suppression of CYP2C11 Gene Transcription by Interleukin-1 Mediated by NF-κB Binding at the Transcription Start Site. Archives of Biochemistry and Biophysics. 377(1). 187–194. 75 indexed citations
3.
Iber, Heinrich, et al.. (1999). MODULATION OF DRUG METABOLISM IN INFECTIOUS AND INFLAMMATORY DISEASES*. Drug Metabolism Reviews. 31(1). 29–41. 55 indexed citations
4.
Morgan, Edward T., Marion B. Sewer, Heinrich Iber, et al.. (1998). Physiological and pathophysiological regulation of cytochrome P450.. PubMed. 26(12). 1232–40. 47 indexed citations
5.
Iber, Heinrich & Edward T. Morgan. (1998). Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11.. PubMed. 26(10). 1042–4. 16 indexed citations
6.
Iber, Heinrich, Qi Chen, Marion B. Sewer, & Edward T. Morgan. (1997). Regulation of Hepatic Cytochrome P450 2C11 by Glucocorticoids. Archives of Biochemistry and Biophysics. 345(2). 305–310. 35 indexed citations
7.
Iber, Heinrich. (1996). Sequence specific binding of cytosolic proteins to a 12 nucleotide sequence in the 5′ untranslated region of FMR1 mRNA. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1309(3). 167–173. 3 indexed citations
8.
Iber, Heinrich, G. van Echten, & Konrad Sandhoff. (1992). Fractionation of Primary Cultured Cerebellar Neurons: Distribution of Sialyltransferases Involved in Ganglioside Biosynthesis. Journal of Neurochemistry. 58(4). 1533–1537. 32 indexed citations
10.
Iber, Heinrich, G. van Echten, & Konrad Sandhoff. (1991). Substrate specificity of α2↔3‐sialyltransferases in ganglioside biosynthesis of rat liver golgi*. European Journal of Biochemistry. 195(1). 115–120. 37 indexed citations
11.
Iber, Heinrich, et al.. (1990). pH-dependent changes of ganglioside biosynthesis in neuronal cell culture.. PubMed. 52(2). 236–40. 24 indexed citations
12.
Echten, G. van, Heinrich Iber, Henrik U. Stotz, Akira Takatsuki, & Konrad Sandhoff. (1990). Uncoupling of ganglioside biosynthesis by Brefeldin A.. PubMed. 51(1). 135–9. 103 indexed citations
13.
Iber, Heinrich & Konrad Sandhoff. (1989). Identity of GD1C, GT1a and GQ1b synthase in Golgi vesicles from rat liver. FEBS Letters. 254(1-2). 124–128. 21 indexed citations
14.
Iber, Heinrich, et al.. (1989). Identity of GA1, GM1a and GD1b synthase in Golgi vesicles from rat liver. FEBS Letters. 248(1-2). 18–22. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026